33
Participants
Start Date
February 26, 2019
Primary Completion Date
June 20, 2019
Study Completion Date
February 20, 2020
recombinant anti-rabies human monoclonal antibody injection (SYN023)
The finished product of SYN023 is a mixture of two anti-rabies human monoclonal antibodies, CTB011 and CTB012 by equal quantity, containing 3.0 mg/mL active ingredients in both.
Rabies Vaccine
The Chinese licensed Vero Cell Freeze-dried Rabies Vaccine was injected to Cohort B as per the vaccination precedure on Days 1, 4, 8, 15, 28 respectively.
Jilin University, Changchun
Synermore Biologics (Suzhou) Co., Ltd.
INDUSTRY